Bull case
Estee Lauder Cos is supported by a broad-based recovery that is becoming more visible across North America, China, and travel retail, with 4Q organic sales up 5% and Mainland China posting 7% organic growth alongside a sixth consecutive quarter of prestige share gains. The company’s positive outlook also reflects stronger execution in high-growth channels such as social commerce, specialty-multi, and digital, plus a richer innovation pipeline in skincare, fragrance, and makeup that should help sustain growth as FY27 organic sales are expected to run at 3% to 5% with operating margins of 12.7% to 13.5%. Equally important, PRGP restructuring is improving profitability and agility, targeting $1.2 billion of gross benefits and enabling operating leverage, while a well-diversified brand portfolio and China-for-China localization support long-term share gains.